StratDeck

Two stocks in Healthcare

Alcon vs Lonza Group: profit, growth, debt and price compared

Alcon and Lonza Group are each stronger on 3 of 7 figures: Alcon on profit margin, debt and price for its expected profit; Lonza Group on sales growth, dividend and price trend.

Figures as of 18 November 2026Yahoo Finance
Explore Alcon's storyWhere next ↓

Save both stocks to your watchlist and revisit their latest fundamentals.

Alcon and Lonza Group side by side
AlconALC.SWLonza GroupLONN.SW
Net marginStronger: 6.1%−1.6%
Revenue growth, past year+4.70%Stronger: +11.20%
Debt to equityStronger: 24.6%51.1%
Forward P/EStronger: 17.3×29.7×
Dividend yield0.45%Stronger: 0.75%
AnalystsBuy · 17Buy · 23
From its 200-day average+7.2%Stronger: +17.8%

Share price over the past year

  • Alcon+1.5%
  • Lonza Group+23.6%

17 Nov 202518 Nov 2026

Alcon or Lonza Group: which is stronger?

  • ALC.SW

    Which is more profitable?

    Alcon keeps more of each sale as profit: 6.1% against −1.6%.

  • LONN.SW

    Which is growing its sales faster?

    Lonza Group is growing its sales faster: +11.20% over the past year, against +4.70%.

  • ALC.SW

    Which has borrowed less?

    Alcon has borrowed less: its debt is 24.6% of what its shareholders own, against 51.1% for Lonza Group.

  • ALC.SW

    Which costs less for the profit it is expected to make?

    Alcon costs less for the profit it is expected to make: 17.3× its forward earnings, against 29.7×.

  • LONN.SW

    Which pays more in dividends?

    Lonza Group pays more back in dividends for what a share costs: 0.75% a year, against 0.45%.

  • Which do analysts rate higher?

    Analysts rate both the same: Buy.

  • LONN.SW

    Which is in the stronger price trend?

    Lonza Group's price is in the stronger trend: 17.8% above its 200-day average, against 7.2% above.

What each company does

ALC.SWAlcon

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide.

Reports results on 23 February 2027

LONN.SWLonza Group

Lonza Group AG, together with its subsidiaries, operates as a contract development and manufacturing organization for pharma and biotech companies in Europe, North and Central America, Latin America, Asia, Australia, and internationally.

Reports results on 27 January 2027

This comparison is just the starting point.

Discover opportunities, understand companies and compare investments in one place. See how StratDeck works

Keep researching

Where next

Every European healthcare comparison

Free email

Up to speed in minutes, four times a week

Every Monday, know what moved AI stocks and what to watch next. Every Wednesday and Friday, find a stock worth a look and learn its story. Every Sunday, catch up on the market's week in two minutes.

Early access

Become a StratDeck founding user

Use StratDeck, tell us what's missing, and help decide what we build next.

100 founding places. Founding users get their first month free, then half price for life: £2.99 a month or £30 a year.